(Total Views: 100)
Posted On: 09/29/2020 1:32:56 PM
Post# of 89499

$NBIO’s top asset is Pritumumab which targets brain, lung, breast, and pancreatic cancer
https://biopharmajournal.com/2020/09/29/why-n...close-look
https://biopharmajournal.com/2020/09/29/why-n...close-look


